New Data on PV Studies

Ruben A. Mesa, MD

Video Categories: Polycythemia Vera

Listen as Dr. Mesa discusses exciting new data in polycythemia vera on studies on hydrea coming out of ASCO and ASH.

Supported through funding from Incyte
July 17, 2018

How to Foster Communication Among all Members of the Cancer Care Team with Pathologists to Deliver Individualized Treatment for Patients with Lung Cancer

Drs Roy Herbst and David Rimm consider novel ways that surgeons, interventional radiologists, pulmonologists, medical oncologists, and pathologists interact at Yale Cancer Center to maximize the use of common molecular biomarkers, as well as NGS and TMB, in providing precision medicine to lung cancer patients.

July 29, 2015

Discussing Cost and Value with Patients

Dr. Steve O’Day understands that cost is a major concern for patients and urges oncologists to discuss the “big picture” with their patients so that they understand the full value of a treatment.